Nelson Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.23M | Buy |
6,027
+1,596
| +36% | +$1.63M | 0.79% | 23 |
|
|
2026
Q1 | $4.08M | Sell |
4,431
-219
| -5% | -$222K | 0.5% | 33 |
|
|
2025
Q4 | $5M | Sell |
4,650
-47
| -1% | -$44.9K | 0.58% | 32 |
|
|
2025
Q3 | $3.58M | Buy |
4,697
+984
| +27% | +$732K | 0.43% | 43 |
|
|
2025
Q2 | $2.89M | Buy |
3,713
+47
| +1% | +$36.5K | 0.38% | 49 |
|
|
2025
Q1 | $3.03M | Buy |
3,666
+44
| +1% | +$36.6K | 0.52% | 45 |
|
|
2024
Q4 | $2.8M | Buy |
3,622
+3,296
| +1,011% | +$2.73M | 0.46% | 45 |
|
|
2024
Q3 | $289K | Hold |
326
| – | – | 0.05% | 91 |
|
|
2024
Q2 | $295K | Hold |
326
| – | – | 0.05% | 92 |
|
|
2024
Q1 | $254K | Buy |
+326
| New | +$232K | 0.05% | 94 |
|
|
2019
Q4 | – | Sell |
-950
| Closed | -$106K | – | 208 |
|
|
2019
Q3 | $106K | Buy |
950
+100
| +12% | +$11.1K | 0.03% | 112 |
|
|
2019
Q2 | $94K | Buy |
850
+400
| +89% | +$47.1K | 0.02% | 117 |
|
|
2019
Q1 | $58K | Hold |
450
| – | – | 0.01% | 127 |
|
|
2018
Q4 | $52K | Hold |
450
| – | – | 0.01% | 127 |
|
|
2018
Q3 | $48K | Hold |
450
| – | – | 0.01% | 136 |
|
|
2018
Q2 | $38K | Hold |
450
| – | – | 0.01% | 135 |
|
|
2018
Q1 | $35K | Sell |
450
-8
| -2% | -$644 | 0.01% | 154 |
|
|
2017
Q4 | $39K | Buy |
458
+133
| +41% | +$11.3K | 0.01% | 152 |
|
|
2017
Q3 | $28K | Hold |
325
| – | – | 0.01% | 162 |
|
|
2017
Q2 | $27K | Hold |
325
| – | – | 0.01% | 165 |
|
|
2017
Q1 | $27K | Hold |
325
| – | – | 0.01% | 166 |
|
|
2016
Q4 | $24K | Hold |
325
| – | – | 0.01% | 168 |
|
|
2016
Q3 | $26K | Sell |
325
-238
| -42% | -$19.1K | 0.01% | 160 |
|
|
2016
Q2 | $44K | Buy |
563
+250
| +80% | +$18.8K | 0.02% | 121 |
|
|
2016
Q1 | $23K | Hold |
313
| – | – | 0.01% | 156 |
|
|
2015
Q4 | $26K | Hold |
313
| – | – | 0.01% | 146 |
|
|
2015
Q3 | $26K | Hold |
313
| – | – | 0.01% | 147 |
|
|
2015
Q2 | $26K | Sell |
313
-50
| -14% | -$3.81K | 0.01% | 166 |
|
|
2015
Q1 | $26K | Hold |
363
| – | – | 0.01% | 164 |
|
|
2014
Q4 | $25K | Hold |
363
| – | – | 0.01% | 168 |
|
|
2014
Q3 | $24K | Hold |
363
| – | – | 0.01% | 174 |
|
|
2014
Q2 | $23K | Sell |
363
-100
| -22% | -$5.97K | 0.01% | 180 |
|
|
2014
Q1 | $27K | Buy |
463
+163
| +54% | +$9.1K | 0.01% | 144 |
|
|
2013
Q4 | $15K | Hold |
300
| – | – | 0.01% | 163 |
|
|
2013
Q3 | $15K | Hold |
300
| – | – | 0.01% | 160 |
|
|
2013
Q2 | $15K | Buy |
+300
| New | +$16.3K | 0.01% | 158 |
|
Other funds holding LLY
SC
ONB
GIM
Nelson Capital Management's LLY Position: Q2 2026 in Review
Nelson Capital Management increased its Eli Lilly (LLY) stake by 36% in Q2 2026, buying an estimated $1.63M and bringing the position to 6,027 shares worth $7.23M. The position accounts for 0.79% of the portfolio, ranked #23.
Nelson Capital Management first reported a position in LLY in Q2 2013 and has held it in 36 quarters since. 1,713 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Nelson Capital Management held 6,027 shares of Eli Lilly worth $7.23M as of Q2 2026.
- Nelson Capital Management bought 1,596 Eli Lilly shares in Q2 2026, an estimated $1.63M.
- Eli Lilly made up 0.79% of Nelson Capital Management's portfolio in Q2 2026, its #23 holding.
- Nelson Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 36 quarters since.
- 1,713 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.